HBK Investments’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-68,600
| Closed | -$2.4M | – | 732 |
|
|
2019
Q1 | $2.4M | Buy |
68,600
+43,100
| +169% | +$1.51M | 0.02% | 339 |
|
|
2018
Q4 | $847K | Buy |
25,500
+8,457
| +50% | +$281K | 0.01% | 654 |
|
|
2018
Q3 | $858K | Sell |
17,043
-9,903
| -37% | -$499K | 0.01% | 647 |
|
|
2018
Q2 | $1.61M | Sell |
26,946
-28,770
| -52% | -$1.72M | 0.01% | 473 |
|
|
2018
Q1 | $2.55M | Buy |
55,716
+16,816
| +43% | +$770K | 0.02% | 369 |
|
|
2017
Q4 | $1.55M | Buy |
+38,900
| New | +$1.55M | 0.01% | 467 |
|
|
2016
Q4 | – | Sell |
-10,635
| Closed | -$263K | – | 816 |
|
|
2016
Q3 | $263K | Buy |
+10,635
| New | +$263K | ﹤0.01% | 675 |
|
|
2016
Q2 | – | Sell |
-33,300
| Closed | -$508K | – | 1022 |
|
|
2016
Q1 | $508K | Sell |
33,300
-21,100
| -39% | -$322K | ﹤0.01% | 670 |
|
|
2015
Q4 | $731K | Sell |
54,400
-7,100
| -12% | -$95.4K | 0.01% | 572 |
|
|
2015
Q3 | $863K | Buy |
+61,500
| New | +$863K | 0.01% | 546 |
|